AI unsettles global IP rules, while cross-border collaboration tests pharma-patent control

Artificial intelligence is reshaping intellectual property law in patenting and trade secrets, exposing gaps across jurisdictions and adding pressure on innovation policy, according to discussions at an international symposium held in...

Already a subscriber? Click here to view full article